Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006 Mar;5(3):228-34. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. St. Louis: Biomarkers Pre-dementia—Like eFAD, Like LOAD?
  2. An Oligomer Test for PD—Could One for AD Be Close Behind?
  3. Common Ground: Is Aβ the Foundation for Multiple Dementias?
  4. Still Early Days for α-synuclein Fluid Marker
  5. In Healthy Brains, Does Aβ Really Matter?
  6. Triple Confirmation: AD Footprint in CSF of Cognitively Normal People
  7. Alzheimer Activism: How To Modernize Clinical Trials?
  8. Research Brief: More Evidence That CSF Aβ Changes Precede AD
  9. CSF Biomarkers Track With Atrophy, Cognition in Normal Aging
  10. More ADNI Results 2: It’s All About Power
  11. Sweet 16: Novel APP Processing Pathway and a New Biomarker?
  12. Subjective Memory Complaint—Not So Subjective Anymore?
  13. Tau Biomarkers—More Informative Fragments in Spinal Fluid?
  14. At AAIC, Researchers Debate Neurogranin's Measure as a Marker

Webinars

  1. Untapped Resource? New Study to Boost Acceptance of CSF Analysis

Research Timeline Event

  1. CSF Aβ/tau signature identifies prodromal AD within MCI cohorts, predicts cognitive decline